Extended Data Fig. 4: Absolute and relative risk of common ( > 10% at least in one arm) non-serious adverse events. | Nature Medicine

Extended Data Fig. 4: Absolute and relative risk of common ( > 10% at least in one arm) non-serious adverse events.

From: Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial

Extended Data Fig. 4: Absolute and relative risk of common ( > 10% at least in one arm) non-serious adverse events.The alternative text for this image may have been generated using AI.

4 A. Absolute risk of non-serious AEs by group. The dots and triangles represent the percentage of patients experiencing AE of those who received low-dose IL-2 (red dot) or placebo (blue triangle). 4 B. The dot is the estimate of the relative risk of the AE comparing IL-2 to Placebo. The error bars represent the 95% confidence interval for that estimate. Placebo n = 31, Low-dose IL-2 n = 32.

Back to article page